Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 16;21(12):4294.
doi: 10.3390/ijms21124294.

Cellular Models and Assays to Study NLRP3 Inflammasome Biology

Affiliations
Review

Cellular Models and Assays to Study NLRP3 Inflammasome Biology

Giovanni Zito et al. Int J Mol Sci. .

Abstract

The NLRP3 inflammasome is a multi-protein complex that initiates innate immunity responses when exposed to a wide range of stimuli, including pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs). Inflammasome activation leads to the release of the pro-inflammatory cytokines interleukin (IL)-1β and IL-18 and to pyroptotic cell death. Over-activation of NLRP3 inflammasome has been associated with several chronic inflammatory diseases. A deep knowledge of NLRP3 inflammasome biology is required to better exploit its potential as therapeutic target and for the development of new selective drugs. To this purpose, in the past few years, several tools have been developed for the biological characterization of the multimeric inflammasome complex, the identification of the upstream signaling cascade leading to inflammasome activation, and the downstream effects triggered by NLRP3 activation. In this review, we will report cellular models and cellular, biochemical, and biophysical assays that are currently available for studying inflammasome biology. A special focus will be on those models/assays that have been used to identify NLRP3 inhibitors and their mechanism of action.

Keywords: NLRP3; NLRP3 inhibitors; biochemical assays; biophysical assays; cell models; inflammasome; read-outs.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of the mechanisms regulating inflammasome activation in canonical, non-canonical and alternative pathway. Abbreviations: PAMP, pathogen-associate molecular pattern; TLRs, toll-like receptors; NF-kB, nuclear factor kappa-light-chain-enhancer of activated B cells; PTM, post-translational modifications; eATP, extracellular adenosine triphosphate; mROS, mitochondrial reactive oxygen species; ASC, apoptosis-associated speck-like protein containing a CARD; IL, interleukin; GSDMD, gasdermin D; iLPS, intracellular LPS; TRIF, TIR-domain-containing adapter-inducing interferon-β; RIPK, receptor-interacting serine/threonine-protein kinase 1; FADD, Fas-associated protein with death domain; NLRP3, NLR family pyrin domain containing 3.

References

    1. He Y., Zeng M.Y., Yang D., Motro B., Núñez G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature. 2016;530:354–357. doi: 10.1038/nature16959. - DOI - PMC - PubMed
    1. Quartier P., Rodrigues F., Georgin-Lavialle S. Cryopyrin-Associated periodic syndromes. Rev. Med. Interne. 2018;39:287–296. doi: 10.1016/j.revmed.2017.09.002. - DOI - PubMed
    1. Heneka M.T., Kummer M.P., Stutz A., Delekate A., Schwartz S., Vieira-Saecker A., Griep A., Axt D., Remus A., Tzeng T.C., et al. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature. 2013;493:674–678. doi: 10.1038/nature11729. - DOI - PMC - PubMed
    1. Wang X., Chi J., Huang D., Ding L., Zhao X., Jiang L., Yu Y., Gao F. Alpha-Synuclein promotes progression of Parkinson’s disease by upregulating autophagy signaling pathway to activate NLRP3 inflammasome. Exp. Med. 2020;19:931–938. - PMC - PubMed
    1. Olcum M., Tastan B., Kiser C., Genc S., Genc K. Microglial NLRP3 inflammasome activation in multiple sclerosis. Adv. Protein Chem. Struct. Biol. 2020;119:247–308. - PubMed

LinkOut - more resources